All stock lists
Arbutus Biopharma Corp (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
Healthcare · Biotechnology
4.22+0.02 (+0.48%)
Market cap
$647M
Website
Insider Score
––Not scored
ABUS Insider Score
Insiders here have filed 12 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ABUS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.01 M | 179.13 M | 1.05 M | 529.00 K | 10.74 M | — |
| Revenue Growth (YoY) | -90.56 % | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 3.87 M | 5.89 M | 3.69 M | 3.04 M | 3.33 M | — |
| R&D Expense | 2.90 M | 4.12 M | 5.01 M | 5.78 M | 5.50 M | — |
| Operating Expenses | 6.76 M | 10.01 M | 8.70 M | 8.82 M | 8.83 M | — |
| Operating Income | -5.75 M | 169.12 M | -7.64 M | -8.29 M | 1.91 M | — |
| Pretax Income | -5.14 M | 169.69 M | -3.76 M | -7.74 M | 2.52 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -5.14 M | 169.69 M | -3.76 M | -7.74 M | 2.52 M | — |
| EPS (Basic) | -0.03 | 0.88 | — | -0.04 | 0.01 | -0.13 |
| EPS (Diluted) | -0.03 | 0.87 | — | -0.04 | 0.01 | -0.13 |
| Shares Outstanding | 197.47 M | 193.77 M | — | 191.78 M | 191.55 M | 190.71 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.